PTEN loss was previously described in lung cancer and several additional tumor types, most notably in glioblastoma [59,60], endometrial [61], ovarian [62] and prostate cancers [63], and to a lesser extent in breast and colon cancers [64,65]. This evidence concerns the gene PTEN and malignant colon neoplasm.